PMID- 30677468 OWN - NLM STAT- MEDLINE DCOM- 20190924 LR - 20210816 IS - 1878-4216 (Electronic) IS - 0278-5846 (Linking) VI - 92 DP - 2019 Jun 8 TI - Estrogen receptor 1 gene variants and estradiol activities in alcohol dependence. PG - 301-307 LID - S0278-5846(18)30611-0 [pii] LID - 10.1016/j.pnpbp.2019.01.008 [doi] AB - OBJECTIVE: Alcohol use disorders inflict a great individual and societal burden. Although sex hormone effects have been implicated in alcohol dependence, research has mostly neglected estrogen activities and female alcohol-dependent patients. Here, we investigated associations of estrogen receptor 1 (ESR1) genetics and serum estradiol activities with aspects of alcohol dependence. METHOD: Serum estradiol activities of early-abstinent alcohol-dependent in-patients (n[male symbol] = 113, n[female symbol] = 87) were followed for at median 5 days and compared with healthy controls (n[male symbol] = 133, n[female symbol] = 107). All participants were genotyped for five ESR1 single nucleotide polymorphisms (rs6902771, rs11155819, rs6557171, rs2982683, rs2982712). RESULTS: Bioavailable estradiol levels decreased during withdrawal treatment (P[male symbol] < .001, P[female symbol] = .011). Male patients with an increase of bioavailable estradiol during withdrawal showed fewer days to (P = .033) and more alcohol-related readmissions (P < .05) during the 12-month follow-up. Higher estradiol and estradiol-to-testosterone activities were significantly related to liver, muscle, and cell count damage in male patients. Estradiol-to-testosterone activities in female patients were lower compared to female controls (total P = .013, bioavailable P = .009). Moreover, the ESR1 genotypes jointly separated alcohol-dependent patients from controls (P = .037). CONCLUSION: Our findings support the role of ESR1 genetics in alcohol dependence and show for the first time that estradiol activities may sex-specifically predict alcohol-related sequelae and outcome following in-patient withdrawal treatment. CI - Copyright (c) 2019. Published by Elsevier Inc. FAU - Muhle, Christiane AU - Muhle C AD - Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nurnberg (FAU), Germany. Electronic address: christiane.muehle@uk-erlangen.de. FAU - Barry, Brianna AU - Barry B AD - Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nurnberg (FAU), Germany. Electronic address: bbarry3@jhmi.edu. FAU - Weinland, Christian AU - Weinland C AD - Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nurnberg (FAU), Germany. Electronic address: christian.weinland@uk-erlangen.de. FAU - Kornhuber, Johannes AU - Kornhuber J AD - Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nurnberg (FAU), Germany. Electronic address: johannes.kornhuber@uk-erlangen.de. FAU - Lenz, Bernd AU - Lenz B AD - Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nurnberg (FAU), Germany. Electronic address: bernd.lenz@uk-erlangen.de. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190121 PL - England TA - Prog Neuropsychopharmacol Biol Psychiatry JT - Progress in neuro-psychopharmacology & biological psychiatry JID - 8211617 RN - 0 (ESR1 protein, human) RN - 0 (Estrogen Receptor alpha) RN - 3XMK78S47O (Testosterone) RN - 4TI98Z838E (Estradiol) SB - IM MH - Adult MH - Alcoholism/blood/*genetics MH - Case-Control Studies MH - Estradiol/*blood MH - Estrogen Receptor alpha/*genetics MH - Female MH - Genotype MH - Humans MH - Inpatients MH - Male MH - Middle Aged MH - Polymorphism, Single Nucleotide/genetics MH - Sex Characteristics MH - Substance Withdrawal Syndrome/blood MH - Testosterone/blood OTO - NOTNLM OT - Alcohol dependence OT - Bioavailable fraction OT - Estradiol OT - Estrogen receptor 1 gene OT - Readmission OT - Sex-differences EDAT- 2019/01/25 06:00 MHDA- 2019/09/26 06:00 CRDT- 2019/01/25 06:00 PHST- 2018/08/07 00:00 [received] PHST- 2018/12/29 00:00 [revised] PHST- 2019/01/20 00:00 [accepted] PHST- 2019/01/25 06:00 [pubmed] PHST- 2019/09/26 06:00 [medline] PHST- 2019/01/25 06:00 [entrez] AID - S0278-5846(18)30611-0 [pii] AID - 10.1016/j.pnpbp.2019.01.008 [doi] PST - ppublish SO - Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:301-307. doi: 10.1016/j.pnpbp.2019.01.008. Epub 2019 Jan 21.